WWOX : A candidate tumor suppressor gene involved in multiple tumor types
- 25 September 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (20) , 11417-11422
- https://doi.org/10.1073/pnas.191175898
Abstract
We previously reported the construction of a P1-derived artificial chromosome (PAC) contig encompassing a set of homozygous deletions of chromosome 16q23–24.1 found in primary ovarian tumor material and several tumor cell lines. Using these PAC clones in a cDNA selection experiment, we have isolated a Sau 3A fragment homologous to the WWOX transcript (GenBank accession no. AF211943 ) from normal human ovarian surface epithelial (HOSE) cells. We demonstrate the homozygous deletion of WWOX exons from ovarian cancer cells and three different tumor cell lines. We also identify an internally deleted WWOX transcript from a further primary ovarian tumor. In three of these samples the deletions result in frameshifts, and in each case the resulting WWOX transcripts lack part, or all, of the short chain dehydrogenase domain and the putative mitochondrial localization signal. Sequencing revealed several missense polymorphisms in tumor cell lines and identified a high level of single nucleotide polymorphism (SNP) within the WWOX gene. This evidence strengthens the case for WWOX as a tumor suppressor gene in ovarian cancer and other tumor types.Keywords
This publication has 17 references indexed in Scilit:
- WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.2000
- Muir–Torre-like syndrome in Fhit-deficient miceProceedings of the National Academy of Sciences, 2000
- Chromosomal fragile site FRA16D and DNA instability in cancer.2000
- A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.2000
- Cancer-specific chromosome alterations in the constitutive fragile region FRA3 BProceedings of the National Academy of Sciences, 1999
- Role of FHIT in Human CancerJournal of Clinical Oncology, 1999
- Deletion mapping of chromosome 16q in hepatocellular carcinomaBritish Journal of Cancer, 1999
- Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus.1999
- FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.1997
- Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.1996